Clinical Trial Update: Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating risk-adapted de-intensification of radiochemotherapy for oropharyngeal squamous cell carcinoma; the trial is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: University of Florida | Conditions: Oropharyngeal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING